Old Web
English
Sign In
Acemap
>
Paper
>
Abstract A101: The MetAction trial: long-lasting responses to molecularly matched therapy in end-stage cancer
Abstract A101: The MetAction trial: long-lasting responses to molecularly matched therapy in end-stage cancer
2018
Anne Hansen Ree
Kjersti Flatmark
Vigdis Nygaard
Daniel Heinrich
Kjetil Boye
Svein Dueland
Vegard Nygaard
Eivind Hovig
Klaus Beiske
Marius Lund-Iversen
Vivi Ann Flørenes
Christin Johansen
Inger Riise Bergheim
Menaka Sathermugathevan
Sigve Nakken
Gry A. Geitvik
Ole Christian Lingjærde
Anne Lise Børresen-Dale
Hege G. Russnes
Gunhild Mari Mælandsmo
Keywords:
Econometrics
Oncology
End stage cancer
Internal medicine
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]